Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
19 results
D2.90 - Potato Allergy in Children: Clinical Features, Laboratory Findings, and Tolerance Development
D2.91 - Exploring Geographic Differences in Ragweed and Mugwort Hypersensitivity Among Patients with Respiratory Symptoms of Allergy in Eastern and Western Europe
D2.100 - Carcinoid Crisis Mimicking IgE-Mediated Hypersensitivity Reaction During Peptide Receptor Radionuclide Therapy (PRRT): A Diagnostic Dilemma
D2.102 - Hidden metal triggers in allergic contact dermatitis
D2.103 - Severe Persistent Allergic Rhinitis in an Adolescent: A SNOT-22–Based Case Report
D2.104 - Mental Health Care and Support in Patients with Atopic Dermatitis in Kazakhstan: One-Year Follow-Up Study
D2.92 - LTP-Mediated Corn-Induced Anaphylaxis
D2.93 - The role of tropomyosins in allergenic cross-reactivity
D2.94 - Anaphylaxis to human serum albumin in a patient with liver cirrhosis – a diagnostic challenge
D2.95 - Comparative Molecular IgE Sensitization Patterns Across Developmental Stages: A Cross-Sectional Study in Clinical Cohorts from Ankara and Tehran
D2.96 - Perioperative Anaphylaxis in Sri Lanka: Evaluation in a Low-Resource Setting
D2.97 - Overall Prevalence and Particular Importance of Studying Sensitization to Peanut Molecules
D2.98 - Allergic Contact Dermatitis from 2-Hydroxyethyl Methacrylate in a Nail Technician
D2.99 - The mysterious cases of anaphylaxis to döner kebab in Germany/Switzerland with subsequent tolerance in Türkiye: an unwelcome guest causes trouble
- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells
- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study
- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib
- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series
- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis
Download the app
The congress at your fingertips
Available on
Download